D&D Pharmatech Inc. (KOSDAQ:347850)
South Korea · Delayed Price · Currency is KRW 80,800
+3,300 (4.26%)
Feb 9, 2026, 9:18 AM KST
D&D Pharmatech Market Cap
D&D Pharmatech has a market cap or net worth of 3.37 trillion as of February 6, 2026. Its market cap has increased by 492.33% in one year.
Market Cap
3.37T
Enterprise Value
3.34T
Revenue
8.36B
Ranking
n/a
PE Ratio
n/a
Stock Price
80,800.00
Market Cap Chart
Since May 2, 2024, D&D Pharmatech's market cap has increased from 379.56B to 3.37T, an increase of 788.92%. That is a compound annual growth rate of 244.31%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 6, 2026 | 3.37T | -15.58% |
| Dec 30, 2025 | 4.00T | 678.13% |
| Dec 30, 2024 | 513.61B | 35.32% |
| May 2, 2024 | 379.56B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SK Biopharmaceuticals | 8.50T |
| HLB Co., Ltd. | 6.73T |
| LigaChem Biosciences | 6.18T |
| Peptron | 5.77T |
| SK bioscience | 3.84T |
| Voronoi | 3.68T |
| PharmaResearch | 3.53T |
| Hugel | 2.63T |